Genic Co. Ltd Total Liabilities
Genic Co. Ltd total liabilities. Based on the latest financial reports, Genic Co. Ltd (123330) has total liabilities worth ₩35.13 Billion KRW (≈ $23.81 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Genic Co. Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Genic Co. Ltd (2012–2025)
Total liabilities of Genic Co. Ltd from 2012 to 2025. This chart illustrates how Genic Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Genic Co. Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Genic Co. Ltd Competitors by Total Liabilities
The table below lists competitors of Genic Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Coloray International Investment Co. Ltd
KQ:900310
|
Korea | ₩40.22 Billion |
|
Shemen Industries Ltd
TA:SMNIN
|
Israel | ILA88.93 Million |
|
S.D. STANDARD ETC DL-03
F:S1P
|
Germany | €2.15 Million |
|
GCI Liberty, Inc. - Series A GCI Group
NASDAQ:GLIBA
|
USA | $1.52 Billion |
|
Australian Mines Ltd
AU:AUZ
|
Australia | AU$207.00K |
|
The9 Ltd ADR
NASDAQ:NCTY
|
USA | $34.26 Million |
|
NoiBai Cargo Terminal Services JSC
VN:NCT
|
Vietnam | ₫226.39 Billion |
|
Rayence Co. Ltd
KQ:228850
|
Korea | ₩29.87 Billion |
Liability Composition Analysis (2012–2025)
This chart breaks down Genic Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 123330 total assets.
Liquidity & Leverage Metrics
Genic Co. Ltd Total Liabilities Ratios Explained
Genic Co. Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.83 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.63 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.39 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Genic Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Genic Co. Ltd (2012–2025)
The table below shows the annual total liabilities of Genic Co. Ltd from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩15.49 Billion ≈ $10.49 Million |
-3.23% |
| 2024-12-31 | ₩16.00 Billion ≈ $10.84 Million |
+34.81% |
| 2023-12-31 | ₩11.87 Billion ≈ $8.04 Million |
-17.64% |
| 2022-12-31 | ₩14.41 Billion ≈ $9.77 Million |
-44.80% |
| 2021-12-31 | ₩26.11 Billion ≈ $17.70 Million |
-5.95% |
| 2020-12-31 | ₩27.77 Billion ≈ $18.82 Million |
-10.46% |
| 2019-12-31 | ₩31.01 Billion ≈ $21.01 Million |
-9.78% |
| 2018-12-31 | ₩34.37 Billion ≈ $23.29 Million |
-12.11% |
| 2017-12-31 | ₩39.11 Billion ≈ $26.50 Million |
-1.32% |
| 2016-12-31 | ₩39.63 Billion ≈ $26.86 Million |
+36.81% |
| 2015-12-31 | ₩28.97 Billion ≈ $19.63 Million |
+42.39% |
| 2014-12-31 | ₩20.34 Billion ≈ $13.79 Million |
+73.85% |
| 2013-12-31 | ₩11.70 Billion ≈ $7.93 Million |
+62.52% |
| 2012-12-31 | ₩7.20 Billion ≈ $4.88 Million |
-- |
About Genic Co. Ltd
Genic Co., Ltd. researches, develops, manufactures, and sells cosmetics and pharmaceuticals in South Korea and internationally. The company provides hydrogel masks, sheet masks, cream wrapping masks, mud masks, and bio cellulose masks; nose patch, eye patch, body patch, eye gel, lifting patch, and outdoor patches; cleanser, toner, lotion, serum, cream, sunscreen, and cleansing/soothing/oil pad; a… Read more